PMID- 26574547 OWN - NLM STAT- MEDLINE DCOM- 20160516 LR - 20210205 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 291 IP - 2 DP - 2016 Jan 8 TI - Zn2+-dependent Activation of the Trk Signaling Pathway Induces Phosphorylation of the Brain-enriched Tyrosine Phosphatase STEP: MOLECULAR BASIS FOR ZN2+-INDUCED ERK MAPK ACTIVATION. PG - 813-25 LID - 10.1074/jbc.M115.663468 [doi] AB - Excessive release of Zn(2+) in the brain is implicated in the progression of acute brain injuries. Although several signaling cascades have been reported to be involved in Zn(2+)-induced neurotoxicity, a potential contribution of tyrosine phosphatases in this process has not been well explored. Here we show that exposure to high concentrations of Zn(2+) led to a progressive increase in phosphorylation of the striatal-enriched phosphatase (STEP), a component of the excitotoxic-signaling pathway that plays a role in neuroprotection. Zn(2+)-mediated phosphorylation of STEP61 at multiple sites (hyperphosphorylation) was induced by the up-regulation of brain-derived neurotropic factor (BDNF), tropomyosin receptor kinase (Trk) signaling, and activation of cAMP-dependent PKA (protein kinase A). Mutational studies further show that differential phosphorylation of STEP61 at the PKA sites, Ser-160 and Ser-221 regulates the affinity of STEP61 toward its substrates. Consistent with these findings we also show that BDNF/Trk/PKA mediated signaling is required for Zn(2+)-induced phosphorylation of extracellular regulated kinase 2 (ERK2), a substrate of STEP that is involved in Zn(2+)-dependent neurotoxicity. The strong correlation between the temporal profile of STEP61 hyperphosphorylation and ERK2 phosphorylation indicates that loss of function of STEP61 through phosphorylation is necessary for maintaining sustained ERK2 phosphorylation. This interpretation is further supported by the findings that deletion of the STEP gene led to a rapid and sustained increase in ERK2 phosphorylation within minutes of exposure to Zn(2+). The study provides further insight into the mechanisms of regulation of STEP61 and also offers a molecular basis for the Zn(2+)-induced sustained activation of ERK2. CI - (c) 2016 by The American Society for Biochemistry and Molecular Biology, Inc. FAU - Poddar, Ranjana AU - Poddar R AD - From the Departments of Neurology and. FAU - Rajagopal, Sathyanarayanan AU - Rajagopal S AD - From the Departments of Neurology and. FAU - Shuttleworth, C William AU - Shuttleworth CW AD - Neurosciences University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131. FAU - Paul, Surojit AU - Paul S AD - From the Departments of Neurology and Neurosciences University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 spaul@salud.unm.edu. LA - eng GR - R01 NS083914/NS/NINDS NIH HHS/United States GR - UL1 TR001449/TR/NCATS NIH HHS/United States GR - P20 GM109089/GM/NIGMS NIH HHS/United States GR - R01 NS051288/NS/NINDS NIH HHS/United States GR - R01 NS059962/NS/NINDS NIH HHS/United States GR - NS051288/NS/NINDS NIH HHS/United States GR - NS083914/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20151116 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Brain-Derived Neurotrophic Factor) RN - 17885-08-4 (Phosphoserine) RN - EC 2.7.10.1 (Receptor, trkB) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) RN - EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatases, Non-Receptor) RN - EC 3.1.3.48 (Ptpn5 protein, mouse) RN - J41CSQ7QDS (Zinc) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/metabolism MH - Calcium/pharmacology MH - Cyclic AMP-Dependent Protein Kinases/metabolism MH - Enzyme Activation/drug effects MH - Extracellular Signal-Regulated MAP Kinases/*metabolism MH - Female MH - HeLa Cells MH - Humans MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Neurons/drug effects/metabolism MH - Phosphorylation/drug effects MH - Phosphoserine/metabolism MH - Protein Tyrosine Phosphatases, Non-Receptor/*metabolism MH - Rats, Sprague-Dawley MH - Receptor, trkB/*metabolism MH - Signal Transduction/*drug effects MH - Zinc/*pharmacology PMC - PMC4705400 OTO - NOTNLM OT - STEP OT - brain-derived neurotrophic factor (BDNF) OT - extracellular-signal-regulated kinase (ERK) OT - protein phosphorylation OT - tropomyosin receptor kinase OT - tyrosine-protein phosphatase (tyrosine phosphatase) OT - zinc EDAT- 2015/11/18 06:00 MHDA- 2016/05/18 06:00 PMCR- 2017/01/08 CRDT- 2015/11/18 06:00 PHST- 2015/05/06 00:00 [received] PHST- 2015/11/18 06:00 [entrez] PHST- 2015/11/18 06:00 [pubmed] PHST- 2016/05/18 06:00 [medline] PHST- 2017/01/08 00:00 [pmc-release] AID - S0021-9258(20)36213-X [pii] AID - M115.663468 [pii] AID - 10.1074/jbc.M115.663468 [doi] PST - ppublish SO - J Biol Chem. 2016 Jan 8;291(2):813-25. doi: 10.1074/jbc.M115.663468. Epub 2015 Nov 16.